Araki E, Goto A, Kondo T, et al. Japanese clinical practice guideline for diabetes. Diabetol Int. 2020;11:165–223.

PubMed  PubMed Central  Google Scholar 

Broadley M, Chatwin H, Søholm U, et al. The 12-item hypoglycemia impact profile (HIP12): psychometric validation of a brief measure of the impact of hypoglycemia on quality of life among adults with type 1 or type 2 diabetes. BMJ Open Diabetes Res Care. 2022;10: e002890.

PubMed  PubMed Central  Google Scholar 

Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57:3169–76.

CAS  PubMed  PubMed Central  Google Scholar 

Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369:362–72.

CAS  PubMed  Google Scholar 

McCoy RG, Shah ND, Van Houten HK, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35:1897–901.

PubMed  PubMed Central  Google Scholar 

Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.

CAS  PubMed  PubMed Central  Google Scholar 

Signorovitch JE, Macaulay D, Diener M, et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab. 2013;15:335–41.

CAS  PubMed  Google Scholar 

Ritholz M. Is continuous glucose monitoring for everyone? Consideration of psychosocial factors. Diabetes Spectr. 2008;21:287–9.

Google Scholar 

U.K. Prospective Diabetes Study Group. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249–58.

Google Scholar 

Singh H, Gonder-Frederick L, Schmidt K, et al. Assessing hyperglycemia avoidance in people with Type 1 diabetes. Diabetes Manag. 2014;4:263–71.

CAS  Google Scholar 

Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631–40.

PubMed  PubMed Central  Google Scholar 

Targets G. Standards of medical care in diabetes—2022. Diabetes Care. 2022;45:S83–96.

Google Scholar 

Miya A, Nakamura A, Handa T, et al. Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment. J Diabetes Investig. 2021;12:738–46.

CAS  PubMed  Google Scholar 

Miya A, Nakamura A, Suzuki Y, et al. Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: a prospective observational study. Diabetes Obes Metab. 2023;25:1883–9.

CAS  PubMed  Google Scholar 

Miya A, Nakamura A, Handa T, et al. Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring. Sci Rep. 2021;11:9057.

CAS  PubMed  PubMed Central  Google Scholar 

Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593–603.

PubMed  PubMed Central  Google Scholar 

Bradley C, Gamsu DS, Apfel J, et al. Guidelines for encouraging psychological well-being: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med. 1994;11:510–6.

CAS  PubMed  Google Scholar 

Bradley C, Plowright R, Stewart J, et al. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes. 2007;5:57.

PubMed  PubMed Central  Google Scholar 

Elsayed NA, Aleppo G, Aroda VR, et al. Addendum. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2023. Diabetes Care. 2023;46:S49–67.

CAS  PubMed  Google Scholar 

Karter AJ, Warton EM, Lipska KJ, et al. Development and validation of a tool to identify patients with type 2 diabetes at high risk of hypoglycemia-related emergency department or hospital use. JAMA Intern Med. 2017;177:1461–70.

PubMed  PubMed Central  Google Scholar 

Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157:1681–6.

CAS  PubMed  Google Scholar 

Yun JS, Ko SH, Ko SH, et al. Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care. 2013;36:1283–9.

CAS  PubMed  PubMed Central  Google Scholar 

Chelliah A, Burge MR. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging. 2004;21:511–30.

CAS  PubMed  Google Scholar 

Guerci B, Drouin P, Grangé V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the auto-surveillance intervention active (ASIA) study. Diabetes Metab. 2003;29:587–94.

CAS  PubMed  Google Scholar 

Allen N, Whittemore R, Melkus G. A continuous glucose monitoring and problem-solving intervention to change physical activity behavior in women with type 2 diabetes: a pilot study. Diabetes Technol Ther. 2011;13:1091–9.

PubMed  Google Scholar 

Allen NA, Fain JA, Braun B, et al. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract. 2008;80:371–9.

PubMed  PubMed Central  Google Scholar 

Khunkaew S, Fernandez R, Sim J. Demographic and clinical predictors of health-related quality of life among people with type 2 diabetes mellitus living in northern Thailand: a cross-sectional study. Health Qual Life Outcomes. 2019;17:177.

PubMed  PubMed Central  Google Scholar 

Volčanšek Š, Lunder M, Janež A. Health-related quality of life assessment in older patients with type 1 and type 2 diabetes. Healthcare (Basel). 2023;11:2154.

PubMed  Google Scholar 

Benoit SR, Zhang Y, Geiss LS, et al. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality — United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2018;67:362–5.

PubMed  PubMed Central  Google Scholar 

Selvin E, Wang D, Tang O, et al. Glucose patterns in very old adults: a pilot study in a community-based population. Diabetes Technol Ther. 2021;23:737–44.

CAS  PubMed  PubMed Central  Google Scholar 

Pomatto LCD, Davies KJA. The role of declining adaptive homeostasis in ageing. J Physiol. 2017;595:7275–309.

CAS  PubMed  PubMed Central  Google Scholar 

Japan Diabetes Society (JDS)/Japan Geriatrics Society (JGS) Joint Committee on Improving Care for Elderly Patients with Diabetes, Haneda M, Ito H. Glycemic targets for elderly patients with diabetes. J Diabetes Investig. 2017;8:126–8.

Google Scholar 

Alsahli M, Gerich JE. Hypoglycemia, chronic kidney disease, and diabetes mellitus. Mayo Clin Proc. 2014;89:1564–71.

PubMed  Google Scholar 

Hong S, Presswala L, Harris YT, et al. Hypoglycemia in patients with type 2 diabetes mellitus and chronic kidney disease: a prospective observational study. Kidney. 2020;360(1):897–903.

Google Scholar 

Miya A, Nakamura A, Miyoshi H, et al. Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: a randomized controlled trial. J Diabetes Investig. 2018;9:119–26.

CAS  PubMed  Google Scholar 

Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, et al. Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med. 2005;63:215–21.

CAS  PubMed  Google Scholar 

Kovatchev BP. Metrics for glycaemic control - from HbA1c to continuous glucose monitoring. Nat Rev Endocrinol. 2017;13:425–36.

CAS  PubMed  Google Scholar